TOIOncology Institute, Inc.
- Earnings Call Transcripts
The Oncology Institute (TOI) Second Quarter 2026 Earnings Call - ONCOLOGY INSTITUTE INC
Hello and welcome everyone joining today's Starling Oncology's second quarter 2026 earnings call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the ...
- Earnings Call Transcripts
The Oncology Institute (TOI) Second Quarter 2026 Earnings Call - ONCOLOGY INSTITUTE INC
Hello and welcome everyone joining today's Starling Oncology's second quarter 2026 earnings call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the ...
- GlobeNewswire
The Oncology Institute Rebrands as Starling Oncology
CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that it ...
- GlobeNewswire
The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
CERRITOS, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI) a pioneer in value-based community oncology care, today announced that the company will release its second ...
- Analyst Upgrades
BTIG Maintains Buy on Oncology Institute, Raises Price Target to $9
BTIG analyst David Larsen maintains Oncology Institute with a Buy and raises the price target from $8 to $9. ...
- GlobeNewswire
The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity
CERRITOS, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, announced today that it has repaid ...
- Analyst Upgrades
Lake Street Initiates Coverage On Oncology Institute with Buy Rating, Announces Price Target of $10
Lake Street analyst Ben Haynor initiates coverage on Oncology Institute with a Buy rating and announces Price Target of $10. ...
- Analyst Upgrades
Needham Maintains Buy on Oncology Institute, Raises Price Target to $7
Needham analyst Matthew Shea maintains Oncology Institute with a Buy and raises the price target from $5 to $7. ...
- Analyst Upgrades
BTIG Maintains Buy on Oncology Institute, Raises Price Target to $8
BTIG analyst David Larsen maintains Oncology Institute with a Buy and raises the price target from $7 to $8. ...
- GlobeNewswire
The Oncology Institute Chief Medical Officer to Speak on Value-Based Specialty Care at APG Spring Conference
CERRITOS, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Yale D. Podnos, MD, MPH, ...
- GlobeNewswire
The Oncology Institute to Participate in B. Riley Securities Institutional Investor Conference
CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief ...
- Earnings Call Transcripts
The Oncology Institute (TOI) First Quarter 2026 Earnings Call - ONCOLOGY INSTITUTE INC
Hello and welcome everyone joining the Oncology Institute First Quarter 2026 Earnings Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the quest ...
- GlobeNewswire
The Oncology Institute Reports First Quarter 2026 Financial Results
CERRITOS, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI) ("TOI" or the "Company"), one of the largest value-based community oncology groups in the United States, today reported ...
- GlobeNewswire
The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call
CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter ...
- GlobeNewswire
The Oncology Institute Achieves $1.8 Million in Medicare Savings in CMS Enhancing Oncology Model Performance Period 3, Marking Significant Period-Over-Period Improvement
CERRITOS, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ:TOI), a leading value-based oncology practice, achieved $1.8 million in Medicare savings during Performance ...
- GlobeNewswire
The Oncology Institute to Participate in the 25th Annual Needham Healthcare Conference
CERRITOS, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief ...
- GlobeNewswire
The Oncology Institute Names Minh Merchant Chief Legal Officer
CERRITOS, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI), one of the largest value-based oncology groups in the United States, today announced that Minh Merchant has joined ...
- Analyst Upgrades
B. Riley Securities Maintains Buy on Oncology Institute, Raises Price Target to $8
B. Riley Securities analyst Yuan Zhi maintains Oncology Institute with a Buy and raises the price target from $6 to $8. ...
- Analyst Upgrades
Needham Reiterates Buy on Oncology Institute, Maintains $5 Price Target
Needham analyst Matthew Shea reiterates Oncology Institute with a Buy and maintains $5 price target. ...
- Earnings Call Transcripts
The Oncology Institute (TOI) Fourth Quarter 2025 Earnings Call - ONCOLOGY INSTITUTE INC
Greetings, and welcome to the Oncology Institute fourth quarter 2025 earnings call. At this time, all participants are on e-list and only mode. A brief question and answer session will follow the formal presentation. If ...
- GlobeNewswire
The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026
CERRITOS, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI) ("TOI" or the "Company"), one of the largest value-based community oncology groups in the United States, today reported ...
- Analyst Upgrades
Needham Reiterates Buy on Oncology Institute, Maintains $5 Price Target
Needham analyst Matthew Shea reiterates Oncology Institute with a Buy and maintains $5 price target. ...
- Analyst Upgrades
BTIG Reiterates Buy on Oncology Institute, Maintains $7 Price Target
BTIG analyst David Larsen reiterates Oncology Institute with a Buy and maintains $7 price target. ...
- GlobeNewswire
The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
CERRITOS, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI") (NASDAQ:TOI) a pioneer in value-based community oncology care, today announced that the company will release its fourth quarter ...
- GlobeNewswire
The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March
CERRITOS, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ:TOI), a pioneer in value-based community oncology care, today announced that members of its executive leadership team will ...